NEXT-STAGE
MRI in, tau insight out. NEXT‑STAGE infers regional tau burden from routine MRI noninvasive, scalable, and cost‑effective. PET‑complementary, built for research teams in biopharma and academic hospitals.

Precise Prediction of Regional
Biomarkers for Clinical Uses
Algorithm to precisely predict regional accumulation of pathological proteins as a diagnostic tool without PET protocols (Low-Cost / Risk-Free)

Compared to other products, NeuroXT's NEXT-ATN shows superior amyloid positive prediction accuracy and demonstrates excellent performance in tau stage prediction.